Literature DB >> 17158193

Stability of urinary fractionated metanephrines and catecholamines during collection, shipment, and storage of samples.

Jacques J Willemsen1, H Alec Ross, Jacques W M Lenders, Fred C G J Sweep.   

Abstract

BACKGROUND: Measurements of 24-h fractionated urinary metanephrines and catecholamines are used for the diagnosis of pheochromocytoma, but adequate information is needed regarding collection, storage, and shipment conditions.
METHODS: Spot urine samples were collected from 8 healthy volunteers. Aliquots were immediately frozen at -20 degrees C, or acidified to pH 4 and then frozen either directly or after 24 h at room temperature. The remaining urine was left at room temperature for 24 h and then split into one portion that was acidified and one portion that was not. Aliquots were either frozen or allowed to stand at room temperature for an additional 24, 48, 72, 96, and 168 h before freezing. We also tested the efficacy of adding Na(2)EDTA and Na(2)S(2)O(5), as an alternative to acidification for preservation of the catecholamines.
RESULTS: No clinically relevant degradation (<5%) was observed for the fractionated metanephrines under any of the storage conditions. In contrast, in approximately 50% of the untreated samples catecholamines were partially degraded during the first 24 h at room temperature. Immediate acidification, however, prevented degradation, whereas acidification after 24 h prevented further decay. Addition of Na(2)EDTA and Na(2)S(2)O(5) fully prevented degradation of catecholamines during the first 24 h in 4 of 5 cases. In the remaining case, degradation did not exceed 10%.
CONCLUSION: Preservation of samples for measurements of urinary fractionated metanephrines is not necessary if samples are assayed or frozen within 1 week, which is an important advantage if transport of samples is necessary. In contrast, urinary catecholamines require preservation measures during collection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158193     DOI: 10.1373/clinchem.2006.075218

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Determination of urinary catecholamines and metanephrines in cardiac deaths.

Authors:  Tania Hervet; Eric Grouzmann; Silke Grabherr; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2015-12-21       Impact factor: 2.686

2.  Diagnostic performance of urinary metanephrines for the postmortem diagnosis of hypothermia.

Authors:  Cristian Palmiere; Grzegorz Teresiński; Petr Hejna; Patrice Mangin; Eric Grouzmann
Journal:  Forensic Sci Med Pathol       Date:  2014-07-18       Impact factor: 2.007

3.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

Review 4.  Update on Modern Management of Pheochromocytoma and Paraganglioma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrinol Metab (Seoul)       Date:  2017-06

5.  Case report of a phantom pheochromocytoma.

Authors:  Caroline M Joyce; Audrey Melvin; Paula M O'Shea; Seán J Costelloe; Domhnall J O'Halloran
Journal:  Biochem Med (Zagreb)       Date:  2020-06-15       Impact factor: 2.313

Review 6.  Analysis of Catecholamines and Pterins in Inborn Errors of Monoamine Neurotransmitter Metabolism-From Past to Future.

Authors:  Sabine Jung-Klawitter; Oya Kuseyri Hübschmann
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

Review 7.  Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.

Authors:  Jean-Benoît Corcuff; Laurence Chardon; Ines El Hajji Ridah; Julie Brossaud
Journal:  Endocr Connect       Date:  2017-05-31       Impact factor: 3.335

8.  Quantification of normetanephrine in canine urine using ELISA: evaluation of factors affecting results.

Authors:  Katja Höglund; Hanna Palmqvist; Sara Ringmark; Anna Svensson
Journal:  J Vet Diagn Invest       Date:  2021-10-26       Impact factor: 1.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.